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Abstract 
Traditionally, psychotherapy research has used efficacy and effectiveness studies.  Efficacy 
studies have been considered the gold standard for studying clinical interventions and effects due 
to their stringent controls.  While not as scientifically rigorous as efficacy studies, effectiveness 
studies examine clinical interventions with larger and more diverse populations and more real-to-
life treatment protocols.  Unfortunately, effectiveness studies tend to be based on retrospective 
report, sometimes many months or even years after the conclusion of psychotherapy.  The 
growth of technology, in particular smartphone applications (apps) has opened the door to a form 
of effectiveness study that allows for real-time data collection.  The Therapy Outcome 
Management System (TOMS) is an iOS app that offers the potential to collect “big data.” The 
data set for this study included 323 Norm Development Associates, who tracked the outcome 
and alliance of a total 4,110 clients.  Five research questions were considered.  The first research 
question yielded a statistical difference in therapeutic alliance variables between short-term and 
long-term psychotherapy, indicating that long-term psychotherapy patients report statistically 
improved therapeutic alliance across 3 of the 5 variables used.  The second research question 
yielded no significant differences in therapeutic alliance between gender-matched and mixed-
gender client-therapist dyads.  The third research question investigated theoretical orientation/ 
modality in relation to treatment duration and outcome rating, with three of the four variables 
used to measure outcome revealing differences.  The fourth research question observed therapy 
outcome and treatment duration in various countries where psychotherapy is being conducted, 
with significant differences observed.  The fifth research question observed outcome and 
therapeutic alliance between various diagnostic groups. Individuals with a child/adolescent 
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disorder were found to have had statistically higher average outcome ratings in the first 8 
sessions when compared to mood disorders, and those in the substance abuse disorder group 
reported statistically lower therapeutic alliance scores when compared to adjustment disorder, 
anxiety disorder, and child/adolescent disorder.  The 5 research questions reported here illustrate 
and explore the potential of a novel research method involving big data. Implications and 
limitations are considered.  
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Chapter 1 
Introduction 
 
Research evaluating psychotherapy process and outcomes is crucial in the field of clinical 
psychology.  Indeed, commitment to research has become a hallmark of health service 
psychology insofar as it shapes training, guides treatment, and influences policies established by 
the American Psychological Association (APA).  For example, the American Psychological 
Association 2005 Presidential Task Force on Evidence-Based Practice in Psychology (EBPP) 
defined and discussed evidence-based practice in psychology (APA, 2006), emphasizing the 
importance of integrating science and practice, and the commitment to EBPP.   
Other organizations are also evaluating evidence-based psychological psychotherapy, 
such as the National Institute for Health and Clinical Excellence Guidelines (NICE Guidelines) 
and Cochrane Reviews.  Given the centrality of research in understanding psychotherapy, it is 
not surprising that various systems have been identified to study psychotherapeutic process and 
outcome.  
Two primary outcome research systems have been identified in the literature: efficacy 
studies and effectiveness studies (Singal, Higgins, & Waljee, 2014).  Now the ubiquity of 
smartphone applications (apps) make a modified form of effectiveness studies possible, akin to 
what is known in the popular media as “big data.”  The purpose of the current study is to 
introduce and illustrate a new possibility for psychotherapy research based on data collected by 
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psychotherapists using mobile devices.  To put this study in context, it is first important to 
summarize the two traditional approaches to psychotherapy research. 
Efficacy Studies 
 The efficacy study has been considered the “gold standard” in psychotherapy research 
and is often favored in evaluating clinical treatments.  Efficacy studies have been used for 
conducting clinical trials to evaluate specific interventions in treating psychological disorders.  
Thousands of examples of efficacy studies could be offered.  For example, a study by Gloster et 
al. (2011) evaluated whether therapist-guided exposure within cognitive-behavioral 
psychotherapy (CBT) was more effective than CBT treatment without therapist-guided exposure 
in the treatment of agoraphobia.  The results demonstrated that the therapist-guided exposure was 
better for agoraphobic avoidance, overall functioning, and reduction in panic attacks.  This study 
used randomized assignment, control group, 12-session written manualized treatment, specific 
exposure methods, and outcome measures to demonstrate that therapist-guided exposure added 
to the effectiveness of CBT in treatment of agoraphobia.  As this example illustrates, efficacy 
studies tend to be highly controlled and specific to their conditions.  Efficacy studies typically 
include several key elements. 
First, specific inclusion and exclusion criteria are used in order to keep the sample as 
uniform as possible.  In the example cited here, Gloster et al. (2011) accomplished this by using 
participants that met diagnostic criteria of the Diagnostic and Statistical Manual of Mental 
Disorders (4
th
 Ed., text rev.; DSM-IV-TR; American Psychiatric Association, 2000) for panic 
disorder with agoraphobia.  In addition to meeting DSM-IV-TR diagnostic criteria, individuals 
had to score significantly elevated on the Hamilton Anxiety Scale (HAM-A) and the Clinical 
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Global Impression (CGI).  The study used exclusion criteria such as reporting suicidal intent, 
borderline personality disorder diagnosis, psychotic disorders, and alcohol dependence.  All 
participants were required to discontinue all psychopharmacological medication and any other 
psychotherapy.   
Second, participants are randomly selected to be in a control group or the experimental 
group.  Randomization is a key feature of true experiments (as opposed to quasi-experimental 
studies), making this an important part of efficacy studies.  Gloster et al. (2011) also used 
stratified sampling that was conducted by the study center.  There were two treatment groups that 
used two variations of CBT.  Both of these groups used the same content, structure, and 
treatment duration, but had different implementation of exposure. 
Third, there is a control condition where some participants are not receiving the same 
intervention that is being delivered to the experimental group.  Again, this is a requirement of a 
true experiment, and therefore an essential part of efficacy studies.  In the Gloster et al. (2011) 
study, a single wait-list control was used that did not receive either of the CBT interventions. 
Fourth, the treatment is standardized.  That is, researchers assure that the treatment is 
delivered in a predictable and uniformed way across the various therapists and participants of the 
study.  Often this involves developing a treatment manual and then testing to be sure that 
therapists maintain fidelity to the manual.  Gloster et al. (2011) accomplished this by using a 12-
session written manualized treatment protocol that was used over 6 weeks and followed with two 
other sessions.  There were two variations of the CBT protocol in this study.  One variation used 
therapist-guided exposures outside the psychotherapy room.  The other had the therapist rehearse 
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the exposure procedure with the client and encouraged the patient to implement the procedure 
outside of the psychotherapy session. 
Fifth, there are efforts to keep evaluators uninformed regarding the identity of particular 
participants and whether they are in the control group or the experimental group.  In some cases, 
there is also an effort to keep participants from knowing which group they are in, or even an 
effort to keep treatment providers from knowing some information about the treatment group of 
participants.  The Gloster et al. study had their clinical coordination center create the randomized 
list of patients by personnel that were not a part of patient care.  
Sixth, standardized outcome measures with established reliability and validity are used to 
evaluate the efficacy of the intervention.  This typically involves a repeated-measures design 
where the outcome measures are given before and after treatment, and again after a suitable 
follow-up period has passed.  The same measures are given for the control and experimental 
groups.  In the Gloster et al. (2011) study outcome variables were assessed at baseline, mid-
treatment (4
th
 session), post-treatment, and during a 6-month follow-up.  The assessment tools 
included a Structured Interview Guide for the Hamilton Anxiety Scale, Clinical Global 
Impression, number of panic attacks, and agoraphobic avoidance. 
Because of these criteria for efficacy studies, they are particularly well-suited for meta-
analysis.  Meta-analysis is a systemic quantitative review of efficacy research looking at specific 
treatments of a particular mental disorder.  Meta-analytic studies look at a collection of efficacy 
studies to consider the overall effectiveness of treatments, which may then be used for purposes 
of treatment planning and subsequent research.  An example of such a meta-analysis was 
conducted by Vøllestad, Nielsen, and Nielson (2012).  The researchers considered mindfulness- 
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and acceptance-based interventions (MABIs) for treatment of anxiety disorders and other 
comorbid symptoms.  They considered 19 efficacy studies that employed MABIs for patients 
with anxiety disorders and found that MABIs are associated with significant reductions in 
anxiety and comorbid depressive symptoms.  Hundreds of similar examples could be cited. 
It should be noted that efficacy studies may consider treatment groups as compared to 
control groups, evaluate various adaptions of established psychotherapies, and directly compare 
treatments.  An outcome study by Scheeringa, Weems, Cohen, Amaya-Jackson, and Guthrie 
(2011) serves as a good example of comparing treatment to no treatment.  The researchers 
studied whether trauma-focused CBT was effective in treating posttraumatic stress disorder 
(PTSD) in young children.  The patients were assigned to either a 12-session manualized 
treatment or a 12-week wait-list.  The study used interviews and checklists to assess for 
symptoms of PTSD, major depressive disorder, seasonal affective disorder, oppositional defiant 
disorder, and attention deficit/hyperactivity disorder.  The results suggested that the treatment 
was more effective than the wait-list no-treatment group in reducing PTSD symptoms and 
reducing symptoms from comorbid disorders.   
A study by Wagley, Rybarczyk, Nay, Danish, and Lund (2013) provides a good example 
of how an efficacy study can be used to study an adaption to an already established 
psychotherapy.  The research tested the efficacy of a two session abbreviated CBT intervention 
aimed at treating insomnia as a supplement treatment for psychiatric patients.  The study 
employed a group that did not receive the supplement intervention and randomly assigned the 
patients in the groups.  The Pittsburgh Sleep Quality Index (PSQI) and a Patient Health 
Questionnaire-9 (PHQ-9) were used as the outcome instruments.  Results demonstrated that the 
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abbreviated supplemental CBT treatment is beneficial for insomnia and depression in long-term 
psychiatric outpatients.   
Last, a study by Arch et al. (2012) demonstrates how efficacy studies can be used to 
compare different forms of psychotherapy treatments.  This study compared CBT to acceptance 
and commitment therapy (ACT) for the purpose of treating anxiety disorders.  Results suggested 
that ACT and CBT showed similar improvement and that ACT is a viable treatment for anxiety 
disorders.  Efficacy studies show strong possibilities for comparative and explanatory 
psychotherapy outcome research.   
Due to stringent requirements in efficacy research, the results are considered to be 
empirically valid and can easily suggest whether certain psychotherapy approaches should or 
should not be used with particular diagnoses.  But efficacy studies also have limitations.  One of 
the biggest challenges for efficacy studies is their cost.  They are expensive to conduct, almost 
always requiring external funding.  Cost also limits the number of sessions that can be included 
in clinical trials as well as the number of participants included, which means that some efficacy 
studies report the results of relatively brief interventions when longer interventions might be 
common in naturally occurring psychotherapy settings.  Shean (2012) suggests that efficacy 
studies make the assumption that lasting and significant changes occur within a relatively short 
time frame, which is not always the case.  Most efficacy studies used operationalized and/or 
manualized approaches to treatments, and the question is often raised whether these treatments 
reflect the real-life practice of clinicians in the field.  Another limitation of efficacy studies is 
that they often have strict inclusionary and exclusionary criteria.  While this is helpful in the 
laboratory, it may not reflect the complexity of clients most often seek help for mental health 
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concerns.  It is common practice to select participants diagnosed with a single Axis I disorder, 
which is not always indicative of real-life clinical practice where comorbidity can be present 
with various psychological disorders (Shean, 2012).  Another limitation can be a lack of cultural 
sensitivity.  Dependence on manualized treatment might neglect cultural factors that might be 
impacting patient’s symptoms and functioning. Finally, clinical trials are well suited for outcome 
studies, but not for psychotherapy process.  As a result, the studying of outcome and process is 
typically segmented into separate studies rather than looking at the two in concert. 
Effectiveness Studies 
Effectiveness studies, like efficacy studies, can be utilized to evaluate mental health 
treatment and outcome.  Effectiveness studies attempt to examine clinical interventions more 
similar to real-life routine conditions.  These studies use more diverse populations, less-
standardized treatment, and focus on more routine clinical settings (Singal et al., 2014).  
Effectiveness studies attempt to answer whether the clinical intervention in question works in 
real life practice.  Whereas efficacy studies have high internal validity, effectiveness studies are 
able to achieve high external validity and generalize the results to many settings (Patsopoulos, 
2011).  Efficacy studies are able to determine causal relationships between variables, but 
effectiveness studies are more cost-effective which allows them to have larger samples sizes, 
simpler designs, and look at interventions that are difficult to study under a typical efficacy study 
method.  Seligman (1995) used the Consumer Reports study, which evaluated whether patients 
benefited from psychotherapy, as a prime example to demonstrate how effectiveness studies are 
able to provide a different way to study psychotherapy outcome. 
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Effectiveness studies are typically simpler to conduct than efficacy studies and can lack 
the strict structural requirements.  The Consumer Reports study utilized a short 26-question 
survey about mental health treatment that was sent out embedded in their annual questionnaire in 
1994.  The questions asked what kind of therapist the individual met with, what presenting 
problem was addressed, type of psychotherapy, whether the psychotherapy helped, and other 
questions tailored to mental health counseling (Seligman, 1995).  The results provided a large 
sample size of 2,900 individuals that specifically met with mental health professionals and a total 
of 4,100 that saw a combination of mental health professionals, family doctors, and support 
groups (Seligman, 1995).  
 Effectiveness studies also allow for larger-scale and more diverse populations.  One 
study, if simple enough, can be used to reach population groups in various countries, cultures, 
and communities.  Though the Consumer Reports survey was sent out only to their subscribers, it 
could have been distributed in hospitals, medical clinics, mental health clinics, churches, 
community organizations, and any place that has potential contact with individuals that received 
psychotherapy in the past.  Moreover, the Consumer Reports survey could have been translated 
and sent overseas to obtain psychotherapy outcome data from other countries.  The research 
itself can then be used to observe differences and patterns across cultures, ethnicities, geographic 
location, communities, religious, and other demographic domains.   
 Also, effectiveness studies can be used to assess a wider range of interventions than 
efficacy studies.  Efficacy studies typically require standardized and/or manualized treatment 
protocols, but effectiveness studies can observe a large variety of treatments that do not fit these 
stringent requirements.  Treatments can be continuous and long term. Seligman (1995) notes that 
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the Consumer Reports study included treatment durations from one month or less through two 
years or more.  This allows the study of longer-term psychotherapy approaches such as 
psychodynamic, psychoanalytic, existential, gestalt, and other relational approaches to 
psychotherapy.  
 Notably, there are no control groups in effectiveness studies, as there are in efficacy 
studies.  This has significant disadvantages from a scientific perspective, though it does allow for 
cost-effective studies of large samples where hypotheses can be generated for more rigorous 
scientific evaluation in the future.  
 Finally, effectiveness studies can look at many domains and variables related to the 
treatment process.  These variables can include client-clinician rapport, attention, motivation, 
expectation of gain, and many other variables that are often times not observed through 
traditional efficacy studies.  The Consumer Report survey asked for therapist competence and 
reasons for termination, psychotherapy cost, patient satisfaction, health care reimbursement 
policies and limitations on coverage, and other domains parallel to psychotherapy (Seligman, 
1995). 
  Although there are various advantages to an effectiveness study, there are a number of 
important limitations.  Due to the less stringent requirements for controls and manualized 
procedures, experimenters might inadvertently introduce bias into the study by way of sampling 
and item selection on survey questions.  Also, effectiveness studies typically need large sample 
sizes in order to have enough credibility to form conclusions about findings and suggest future 
areas of investigation.  Moreover, results from effectiveness studies are sometimes too general 
and do not possess enough causal or explanatory data for in-depth analysis.  The Consumer 
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Reports study, for example, points to general conclusions suggesting that no specific 
psychotherapy approach was better than another when considering patient satisfaction, and that 
psychologists, psychiatrists, and social workers were not different in their effectiveness as 
therapists (Seligman, 1995), but it was unable to evaluate the nuanced treatment questions that 
can be considered in a highly controlled trial of a manualized treatment. 
Mobile Applications for Outcome Data Collection 
 
While efficacy and effectiveness studies have traditionally been used to gather 
psychotherapy outcome data, developing technology has provided a potential new method to 
gather such information.  Specifically, smartphone applications and their widespread reach have 
a large potential for psychologists and other psychotherapists to gather data for psychotherapy 
research.  Using software to gather psychotherapy research can be seen as an extension of the 
effectiveness study method.  Mobile applications can help gather data quickly and on a 
potentially larger scale then traditional effectiveness and efficacy methods.  Whereas 
effectiveness studies have traditionally been retrospective, asking participants to evaluate their 
experiences months or years after the conclusion of psychotherapy, mobile app technology 
allows for effectiveness data to be collected in real-time, as psychotherapy is occurring. 
One example of this is the Therapy Outcome Management System (TOMS), an 
application (app) for iPhone/iPad operating system (iOS) devices that is currently being used to 
gather psychotherapy outcome data and alliance data (Wiarda & McMinn, 2012).  This app 
allows for clinicians to obtain feedback from their clients regarding psychotherapy outcome and 
session feedback.  Software such as the TOMS and other applications tailored to gather 
psychotherapy data have substantial advantages for clinical and research practices. 
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Using mobile applications that are readily available through common distribution 
channels such as the Apple iTunes Store promotes large distribution and usage.  The open 
availability of the software allows clinicians all over the world to use the app and track patient 
outcome.  The client outcome, session feedback, and demographic information is de-identified 
and stored on a cloud server for research access.  This method allows researchers to access the 
data from anywhere and the data can come from a large number of settings such as psychology 
clinics, primary care clinics, and other centers where psychotherapy is conducted.  Traditional 
efficacy and effectiveness studies can be limited by the sample sizes.  Outcome mobile 
applications such as the TOMS allow for public distribution which encourages very large sample 
sizes for research analysis.   
The adaptability of mobile applications is important when considering psychotherapy 
research applications.  Mobile applications are usually developed and coded by one or more 
programmers.  The software can be tailored and modified to fit specific research needs such as 
client type, intervention method, clinical settings, demographics information, and other domains 
for study.  Even after an application is initially launched the application can be updated, 
modified, and altered for improvements and needed changes.  Using software for psychotherapy 
outcome research adds a level of versatility and adaptability that is difficult to reach with other 
methods of study.  Traditionally once studies have started, there are no ways to modify for 
potential problems.  For example, the TOMS app gathers demographic information and outcome 
data using the ORS and SRS outcome measures.  Hypothetically, the TOMS app could be 
modified to gather other information such as physical characteristics like weight, height, and 
even use other outcome measures that are already established in a clinical setting.  The software 
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can be translated into various languages to accommodate the diversity of the clinical population 
and setting.  Although making modifications to an application would takes resources and time, 
the adaptability of the software allows the data collection to account for all the specific 
characteristics the specific clinical settings needs to observe.      
Thus, one application can be set up to collect information in various clinical settings, with 
multiple language groups, and potentially gather extremely large sample sizes for psychotherapy 
outcome research.  The ability to adapt the software to account for all the demands and needs of 
the clinical settings, and also the ability to endlessly collect psychotherapy outcome data with no 
additional difficulties offers a new potential for psychotherapy outcome research that is not 
common in today’s research.   
Another appeal for using smartphone applications for outcome research is the simplicity 
of use.  Efficacy studies are usually more complicated and take longer to develop than 
effectiveness studies.  Clinicians must usually be trained on a specific intervention and follow a 
specific manualized treatment for a particular study.  In contrast, using a mobile app requires 
only minor changes in how the clinician practices psychotherapy.  The app must be used at the 
beginning and/or end of the psychotherapy to obtain outcome and alliance information but other 
than that, it does not affect the flow of psychotherapy during clinical practice.  The TOMS app, 
as an example, would require the therapist to possess a mobile tablet or phone with the TOMS 
software and simply ask the client to fill out the outcome and alliance measures to gather the 
patient’s feedback.  The ease of use promotes using the app in every psychotherapy session as 
long as the clinician brings it into the psychotherapy room.  Using the app also allows for rapid 
data collection and secure storage of the data.  The software automatically stores and uploads de-
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identified outcome data to a large database for research purposes.  From the clinician’s point of 
view, the application offers outcome tracking and secure storage which is easily accessible for 
clinical purposes.  The amount of outcome data obtained would only be limited by distribution 
and the clinician’s use of the software.  Thus, if the distribution and accessibility is on a world-
wide scale a single app could monitor outcome on multiple continents, and monitor outcome data 
on potentially millions of clients.   
However, there are also potential downsides with using mobile software for 
psychotherapy outcome data collection.  The first and most significant issue is how the app will 
reach the psychotherapy room.  The software app needs to run on a certain type of device, like a 
tablet, so the clinic, clinician, or organization must obtain these devices in some way.  People 
might ask whether certain organizations even allow the use of such software to track outcome 
data, and will the organization deem the software secure enough for confidentiality purposes?   
These questions need to be answered before a large organization adopts a mobile app for 
outcome data collection.  Private practice or smaller organizations might have an easier time 
adopting the software, but the cost of the tablet or device needed to run the software might be a 
challenge for private practitioners and smaller clinics.  A significant challenge is also to figure 
out a method to integrate mobile applications with the electronic health/medical records 
(EHR/EMR).  Although possible, there are formidable obstacles to incorporating a new measure 
in a EHR.  However, there are many relevant applications for the outpatient environment.  The 
most obvious is for clinicial feedback, but it could also create efficient and accurate information 
for payers who require outcome data for continued authorization of care.  This method might be 
a way to cleanly collect the research data, but poses many challenges in security and integration.  
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Another potential issue is the cost of the software.  Even if the software is free to use, it needs to 
provide substantial benefits for the clinician or clinical organization.  The application also needs 
to be in line with the expectations of the clinician.  If the software is not directly benefiting the 
clinical practice and if it does not meet the clinician’s expectations, the software might not be 
used. 
Another issue results directly from the software’s distribution.  If the application is not 
readily available or commonly used, will the application have enough exposure for 
psychotherapy outcome research?  This is especially the case when talking about studying 
specific populations or groups.  If there are significant issues with reaching psychotherapists and 
instilling regular use of the application, the data gathered might not have enough power for 
research purposes.  Even if the device and app are readily available, and are adopted by many 
clinical organizations, there is a question whether clinicians or organizations will use it regularly.  
The software might appear promising and used regularly for a period of time, but it is unknown 
whether the software will be used for weeks, months, or years regularly and consistently.  The 
consistency and regularity of use will affect data collection and whether the data can be used for 
longer-term longitudinal analyses.   
Another issue regarding outcome tracking applications is the developer and development 
costs of such applications.  Although learning how to code and program software is possible, the 
task is usually performed by experts outside the psychotherapy and psychology research fields.  
Developing and modifying such applications requires extensive skill, time, and resources which 
often means hiring professional software developers to build such programs.  Hiring 
professionals for the purposes of application development adds additional expenses to collect the 
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research data.  Even if the application were developed by a researcher, additional modification 
and maintenance of the application might require additional expenses and resources.  The long-
term use of an outcome application for data collection can be cost-effective, but there can be a 
large amount of start-up costs with no fail-proof way to ensure that the application is successful 
in reaching a large number of clinicians and clients. 
Finally, one must consider ethical issues in using software for gathering psychotherapy 
outcome data.  According to the APA (2009), confidentiality and privacy are significant 
challenges that arise when incorporating technology into psychological practice.  Security of the 
information obtained using such applications is essential and must be done with high standards.  
Using mobile applications for patient outcome tracking might require special methods of de-
identification client’s personal information but at the same time allowing long-term tracking of 
each client’s outcome feedback.  If de-identification is not possible from the programming 
standpoint, both obtaining patient consent and ensuring the security of the database are essential.  
Another ethical consideration is how the outcome data will be used.  Will the information be 
used for pure research purposes set by the developer/researcher who created the application, or 
will the data be available for the general or limited public for research and other reasons?  If an 
outcome tracking application becomes vastly popular and accepted by psychotherapy 
practitioners and organizations, third-party payers might eventually want to base psychotherapy 
reimbursements on outcome data obtained for specific clinicians and interventions.  For example, 
if the outcome data and research demonstrates that a specific clinician was able to achieve 
symptom reduction and good outcome using a CBT approach within eight weeks for a specific 
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disorder, third-party payers might not want to pay clinicians or interventions that take longer to 
achieve similar results.   
Ethics regarding confidentiality and how this data collection method will be used is 
something that will need to be addressed and analyzed.  However, the potential for using 
outcome tracking software is unprecedented.  To demonstrate the potential use of a 
psychotherapy outcome application, the TOMS app will be used to answer a number of research 
questions pertaining to psychotherapy.   
The first study will observe changes in therapeutic alliance over various treatment 
durations.  Specifically, the study will compare therapeutic alliance in short-term versus long-
term psychotherapy.  Research has suggested that client’s with lower therapeutic alliance are 
more likely to drop out of psychotherapy (Sharf, Primavera, & Diener, 2010).  Within the TOMS 
app this would be observed within shorter psychotherapy treatment durations.  For the purposes 
of this study, short-term psychotherapy will include psychotherapy that lasts 1 to 8 sessions.  
Treatment that continues past 8 sessions will be considered long-term.  
The second question will ask whether gender differences between client and therapist are 
related to therapeutic alliance and treatment duration.  A study by Wintersteen, Mensinger, and 
Diamond (2005) observed whether gender and racial differences between patient and therapist 
affect therapeutic alliance and treatment retention in adolescents.  Their results suggested that 
gender-matched dyads have higher therapeutic alliance and that the clients in these dyads were 
more likely to complete treatment.  Racial matching suggested higher retention but no significant 
differences between patient-rated alliance.  The TOMS data set will be used to observe the 
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relationship between client/therapist demographics and therapeutic alliance and treatment 
duration.   
The third research question will ask whether theoretical orientation/modality is related to 
treatment duration and outcome.  There are many different theoretical orientations that are used 
by practicing psychotherapists.  From traditional psychoanalysis to newer approaches such as 
Acceptance and Commitment Therapy, most theoretical orientations have some idea of how long 
psychotherapy should last to obtain significant improvements in functioning and symptom 
reduction.  Some approaches traditionally have been known for longer-term psychotherapy such 
as psychoanalytic psychotherapy.  However, long-term psychotherapy has been harder to study 
and as a result less supported empirically.  Cognitive-behavioral psychotherapy and similar 
approaches such as Trauma Focused Cognitive Behavioral Therapy have been shown to be 
effective forms of short-term psychotherapy (Deblinger, Mannarino, Cohen, Runyon, & Steer, 
2011).  A study by McClelland (2014) suggests that CBT initially demonstrated higher scores on 
outcome measures when compared to those of psychodynamic psychotherapy.  However, the 
overall-interaction between time, theoretical modality, and length of psychotherapy suggests that 
patients who stayed in psychotherapy for an average treatment duration achieves similar results 
regardless of theoretical modality.  The TOMS large data set will be used in an attempt to 
replicate these findings and further analyze the interaction between theoretical 
orientation/modality, treatment duration, and patient outcome.    
The fourth question will study whether the psychotherapist’s country of orgin affects 
outcome or alliance ratings.  The TOMS’ app collects information such as age, gender, ethnicity 
of client, and the country where psychotherapy is being conducted.  Factors such as 
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client/therapist demographics and their relationship to psychotherapy are extremely difficult to 
study due to confounding variables that are present within psychotherapy sessions.  However, 
with large amounts of data on thousands of clients, the data might have the power to suggest 
differences in initial outcome ratings related to demographic factors.  The outcome scores will be 
assessed during the first eight sessions of psychotherapy and analyzed. 
The fifth question will observe differences in outcome and alliance ratings related to 
various diagnostic criteria.  A study by Falkenström, Granström, and Holmqvist (2013) observed 
a relationship between alliance and symptom change in psychotherapy patients.  Reduction in 
patient symptoms suggested improvements with therapeutic alliance, and oppositely, diminished 
alliance correlated with worsening of symptoms.  Furthermore, the results suggested that patients 
with reported personality problems showed stronger variance in alliance between sessions when 
compared to other patients.  Though the data from the TOMS app does allow this sort of nuance 
to be investigated, it also allows for large-scale consideration of diagnosis in relation to outcome 
and alliance.  The TOMS app looks at 13 diagnostic categories: adjustment disorder, anxiety 
disorder, child/adolescent disorder, cognitive impairment, dissociative disorder, eating disorder, 
mood disorder, personality disorder, schizophrenia, sexual disorder, sleep disorder, somatoform 
disorder, and substance abuse.  
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Chapter 2 
Methods 
Instruments 
 Therapy Outcome Management System (TOMS).  The TOMS has been available in 
the Apple App store since May, 2012.  Therapists who have bought the app or received a 
redemption code from the developer have been tracking outcome, therapeutic alliance, and 
demographic data for their individual clients.  The app can be used on an iPad or iPhone/iPod 
and is intended to be used in every psychotherapy session to collect therapeutic alliance and 
outcome scores.  The TOMS app has been used to gather psychotherapy outcome and/or working 
alliance data from over 20,000 sessions, with that number continuously increasing.  The TOMS 
app uses two measures, the Session Rating Scale (SRS; Duncan et al., 2013, see Appendix A) to 
measure therapeutic alliance and the Outcome Rating Scale V3.0 (ORS; Miller, Duncan, Brown, 
Sparks, & Cloud, 2013, see Appendix B) to measure psychotherapy outcome.  Both measures 
use a visual analog scale to measure four items in each of the measures.  Traditionally, patients 
were asked at each treatment session to make a visible mark were using paper and pen on the 
spectrum where their perceptions are in the various items.  Each item spectrum on the SRS and 
ORS is ten centimeters in length.  The SRS and ORS are scored by measuring the distance in 
centimeters between the patient’s mark and the left pole of each spectrum.  Once each item is 
scored, the four items in each assessment are added together to obtain the total score. The TOMS 
app uses an iPad or iPhone to administer the SRS and ORS with the same consistency and 
accuracy, though the actual length of the item spectrum depends on the device size rather than 
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being ten centimeters.  The TOMS app handles scoring automatically rather than using the 
manual procedures used with the pencil-and-paper versions.   
The TOMS app allows for the data to be collected electronically in real time on a session-
by-session basis during mental health treatments.  The patient and therapist information is then 
de-identified through security algorithms and the data is uploaded for analysis.  In addition to 
gathering outcome and therapeutic alliance data, the TOMS app provides the option for 
psychotherapists to report demographic information about themselves and their clients, such as 
age, gender, country of practice, level of training, theoretical orientation/modality, and the 
diagnostic category of the presenting problem. 
Session Rating Scale (SRS).  The SRS is a 4-item visual analog measure designed to 
assess working alliance in psychotherapy.  During psychometric evaluation the SRS was 
compared to the Helping Alliance Questionnaire II (HAQ-II; Luborsky et al., 1996).  
Psychometric testing of the SRS suggests that it is a valid and reliable measure of alliance and 
has moderate test-rest stability.  When compared to the HAQ-II, the SRS showed a Cronbach’s 
coefficient alpha of .88, which is similar to the HAQ-II (.90).  Test-rest reliability which was 
calculated using Pearson’s r was .64 (HAQ = .63).  Concurrent validity testing showed there was 
a .48 correlation between the SRS and HAQ-II, suggesting a reasonable degree of concurrent 
validity of the SRS.  The SRS also demonstrated a correlation of .29 between outcome measures 
administered at the end of psychotherapy and during second and third psychotherapy sessions.  
The validity testing suggests that the SRS is moderately related to an established self-report 
measure of alliance (Duncan et al., 2003).     
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Outcome Rating Scale (ORS).  The ORS is a 4-item visual analog measure of overall 
patient well-being. During development it was compared to the Outcome Questionnaire 45.2 
(OQ-45.2; Lambert et al., 1996).  When compared to the OQ-45.2, the ORS showed an internal 
consistency of .93 (Cronbach’s alpha) (OQ-45.2 = .93).  Concurrent validity was compared with 
the OQ-45.2 at various administration times using the Pearson’s r.  The overall correlation 
between the ORS and OQ-45.2 was .59, which indicates moderate concurrent validity.  The 
validity testing suggested that the ORS is similar to an established self-report outcome scale 
(Miller et al., 2003). 
Participants 
Participants for study include the therapists that are currently using the app for outcome 
tracking.  When first installing the app, they are given opportunity to participate as a “Norm 
Development Associate,” which means the data collected from their use of the app are de-
identified and uploaded to a server for psychotherapy research purposes.  Agreeing to be a Norm 
Development Associate constitutes consent for purposes of this study.  As is true of all informed 
consent procedures, users of the TOMS app can choose at any time to discontinue serving as a 
Norm Development Associate.  
As of February, 2015, the TOMS app had 504 Norm Development Associates (140 male, 
173 female, 189 gender not specified, 2 other; age range: 15-72 years) who were tracking 
outcome of a total of 7,318 clients (1,217 male, 3,700 female, 2,401 gender not specified, age 
range: 1-91 years). Patients are ethnically diverse with individuals identifying themselves with a 
specific ethnicity, but most patients did not select an ethnicity (22 Asian, 112 Black, 49 Dutch, 3 
Niet-Dutch, 38 Hispanic/Latino, 17 Indigenous, 714 White, 27 mixed, 28 that indicated other 
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ethnicities, and 6,308 did not select an ethnicity).  Note that ethnicities must be categorized 
somewhat differently than what is typically done in the United States in order to accommodate 
the worldwide distribution and use of the app.  Therapists have various theoretical 
orientation/modality for treating mental health problems.   
Although the TOMS app obtains a large amount of session data, not every therapist that 
uses the app completes all the demographic and diagnostic information about themselves or their 
patients.  Thus, depending on the research question, the data set has been filtered to include only 
the patients and therapists that fill the requirements for that study.   
Procedures 
 This is an archival research endeavor.  Data is securely stored in a web-based server and 
was de-identified so that therapists’ and clients’ identity can never be known.  Each session, 
patient, and therapist has a unique identification number, generated by an MD5 hash technology.  
This allows for a unique and secure identification number to be created with assurance that it 
cannot be unencrypted.  Currently there are two separate data files stored in the server – one for 
the SRS and one for the ORS. 
 Data from the two data files was reorganized and merged using custom software.  Once 
the custom data file was created, it was exported to SPSS for the purposes of this study.  Each of 
the five research questions was analyzed with SPSS. 
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Chapter 3 
Results 
Question 1 
 The first research question investigated therapeutic alliance between short-term and long 
term therapy.  A series of independent samples t-tests were conducted to compare therapeutic 
alliance (measured by the SRS) in short-term versus long-term psychotherapy.  For this analysis 
short-term psychotherapy referred to treatment that consisted of eight or less psychotherapy 
sessions.  Long-term psychotherapy referred to treatment that consisted of nine sessions or more.  
In addition, the data were filtered to include only clients that completed the SRS.  Five variables 
were used to measure differences in therapeutic alliance: SRS slope, most recent SRS total score, 
average SRS total rating, SRS total ratings from first and eighth session.  A linear regression was 
used to calculate the SRS total slope by measuring the slope between each session until the 
eighth session.  The average slope for the first eight sessions was observed for both short-term 
and long-term therapy groups.  The SRS total score from each client’s most recent 
psychotherapy visit was identified and a mean was determined for the patients found within their 
first eight sessions and those individuals that are past eight visits.  The average SRS total 
variable was determined by finding the average SRS total score for each client in both the long-
term and short-term psychotherapy groups.  SRS ratings from the first and eight sessions were 
identified as snapshots of SRS scores in both the short-term and long-term psychotherapy 
groups.  Table 1 describes t-test results and differences found between the variables.     
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Table 1  
Results for Question 1: Differences in Therapeutic Alliance in Short-Term and Long-Term 
Psychotherapy 
 
Variable 
Short-term 
Group 
 
Mean (Std dev) 
Long-term 
Group 
 
Mean (Std dev) 
Differences 
Session 1 SRS Total 
34.55 (5.51) 
N = 1419 
35.38 (5.09) 
N = 852 
t (1906) = 3.64, p < .001, 
Cohen’s d = 0.156     
Session 8 SRS Total 
36.77 (4.50) 
N = 139 
36.90 (4.64) 
N = 758 
t (895) = .06, p = .950 
Most Recent SRS Total 
36.02 (5.22) 
N = 1182 
37.53 (4.52) 
N = 652 
t (1510) = 6.44,  p < .001, 
Cohen’s d = 0.309 
SRS Slope first 8 sessions 
.19 (.75) 
N = 125 
.22 (.64) 
N = 672 
t (795) = .59, p = .555  
Average SRS Total 
35.30 (4.65) 
N = 1642 
36.69 (3.83) 
N = 985 
t (2380.74) = 8.33, p <.001, 
Cohen’s d =  0.326 
 
Note. Short-term group consists of those completing 8 sessions or fewer. Long-term group 
consists of those completing 9 or more sessions.  
 
 
Question 2 
 The second research question investigated therapeutic alliance and treatment duration 
between gender-matched and mixed-gender client-therapist dyads.  An independent samples t-
test was conducted to compare therapeutic alliance and treatment duration between gender-
matched and mixed-gender client-therapist dyads.  Therapist alliance was again measured by the 
SRS and treatment duration was measured by number of attended sessions.  Data analysis of the 
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SRS included these four variables: most recent SRS total score, average SRS total rating, average 
SRS in first 8 session, and average SRS change.  The most recent SRS total score is the 
measured SRS score at the most recent therapy session.  The average SRS total rating was the 
calculated mean of all the completed SRS total ratings from each client.  The average SRS in 
first eight sessions was the calculated mean of the SRS total ratings obtained in the first eight 
sessions of psychotherapy.  The average SRS change was calculated by computing the difference 
from one session to the next and then averaging these change scores.  Table 2 describes t-test 
results and differences found between the variables.      
 
Table 2  
Results for Question 2: Difference in Therapeutic Alliance and Treatment Duration in Gender-
Matched and Mixed-Gender Client-Therapist Dyads. 
 
Variable 
Mixed Gender 
Dyad Group 
 
(N = 1494) 
 
Mean (Std dev) 
Matched 
Gender Dyad 
Group 
(N = 1433) 
 
Mean (Std dev) 
Differences 
Most Recent SRS Total 35.24 (5.87) 34.89 (6.01) t (2116) = 1.34, p = .181 
Average SRS Total 35.03 (5.22) 34.66 (5.48) t (2618) = 1.78, p = .075 
Average SRS in first 8 
Sessions 
34.95 (5.24) 34.58 (5.49) t (2614) = 1.77, p =  .077 
Average SRS Change  .28 (2.80) .46 (3.38) t (1635) = 1.15, p = .248 
Treatment Duration 5.82 (8.02) 5.49 (7.25) t (3082) = 1.15, p = .250 
Note. A matched gender dyad group consists of a client-therapist pair that shares the same 
gender.  A mixed gender dyad group consists of a client-therapist pair that does not share the 
same gender.  The data set only allowed for use of female and male in the gender category. 
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Question 3 
 The third research question investigated theoretical orientation/modality in relation to 
treatment duration and outcome ratings.  A one-way ANOVA was conducted to compare 
treatment duration and outcome ratings of therapy sessions from different psychotherapist 
orientation/modalities.  A Scheffe post-hoc test was used to obtain specific comparisons between 
the theoretical orientation/modalities.  There are nine options for psychotherapists to choose 
from on the TOMS application for theoretical orientation/modality: Cognitive-Behavioral, 
Integrative, Eclectic, Psychodynamic, Family Systems, Humanistic, Interpersonal, Emotion-
Focused, and other.  The treatment duration variable was measured by number of sessions that 
were recorded per client in the TOMS.  The variables used to measure outcome were average 
ORS change, most recent ORS total, average ORS total rating, and average ORS total in first 
eight sessions.  These four outcome variables were calculated identically to the SRS variables in 
Question 2.  Treatment duration was again measured by number of attended sessions.  Tables 3 
displays the one-way ANOVA and Scheffe post hoc differences between the theoretical 
orientation/modalities.  Statistical differences were determined measured by a p value < 0.05.   
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Table 3 
Results for Question 3. One-way ANOVA and Scheffe post hoc results for outcome rating and 
treatment duration variables in theoretical orientation/modality groups. 
Variable F (df)  p Post Hoc differences 
Most Recent ORS Total F (8, 4939) = 10.346 p < 0.001 CBT < IN, EC, OTH 
OTH > CBT, FS, IP 
IP < IN, EC, OTH  
Average ORS Total F (8, 5046) = 10.896 p < 0.001 OTH > CBT, IN, EC, FS, IP 
Average ORS in first 8 
Sessions 
F (8, 5046) = 10.677 p < 0.001 OTH >  CBT, IN, EC, FS, IP 
Average ORS Change  F (8, 3465) = .945 p = 0.478 No statistical differences 
Treatment Duration F (8, 5202) = 10.722 p < 0.001 CBT < IN, EC, FS 
IN > CBT, HU, IP, EFT 
FS > CBT, IP, EFT 
EFT < IN, EC, FS, OTH  
Note. Results include comparing outcome and treatment duration variables between nine 
theoretical orientation/modality groups: Cognitive-Behavioral (CBT), Integrative (IN), Eclectic 
(EC), Psychodynamic (PD), Family Systems (FS), Humanistic (HU), Interpersonal (IP), 
Emotion-Focused (EFT), and Other (OTH).   
 
 
Question 4 
 The fourth research question investigated outcome ratings and treatment duration 
between countries where psychotherapy is being conducted.  A one-way ANOVA was conducted 
to compare outcome ratings of therapy sessions from various countries where the TOMS 
application is being used.  The Scheffe post hoc test was used to measure individual differences 
in outcome ratings between the different countries.  There are currently eleven countries being 
represented within the TOMS data: Australia, Canada, Denmark, Netherlands, New Zealand, 
Norway, Philippines, Romania, Sweden, United Kingdom, and USA.  The variables used to 
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measure outcome were average ORS change, most recent ORS total, average ORS total ratings, 
average ORS total in first eight sessions, and average ORS slope. The first four variables were 
calculated identically to the ORS variables in Question 2.  The average ORS slope was 
calculated by averaging the measured slope of the total ORS ratings from each session to the 
next. Treatment duration was again measured by number of attended sessions.  Table 4 displays 
the one-way ANOVA and Scheffe post hoc differences between countries in which therapy was 
conducted.  Statistical differences were identified by a p value < 0.05. 
Question 5 
 The fifth research question investigated potential differences in outcome and session 
ratings between various diagnostic groups.  A one-way ANOVA was conducted to compare 
outcome and session ratings of therapy sessions from various diagnostic groups within the 
TOMS data.  A Scheffe post hoc test was used to measure individual differences in outcome 
ratings and therapeutic alliance between the various diagnostic groups.  There were at total of 8 
diagnostic categories that had adequate sample size within the TOMS data: Adjustment disorder, 
anxiety disorder, child /adolescent disorder, eating disorder, mood disorder, personality disorder, 
substance abuse, and other.  The variables used to measure outcome were most recent ORS total, 
average ORS total, average ORS in first 8 sessions, average ORS change, and average ORS 
slope.  The variables that are measuring therapeutic alliance are: most recent SRS total, average 
SRS total, average SRS in first 8 sessions, average SRS change, and average SRS slope.  These 
variables were calculated identically to the ORS and SRS variables in previous research 
questions.  Table 5 displays the one-way ANOVA and Scheffe post hoc differences between 
diagnostic criteria label of clients.  Statistical differences were identified by a p value < 0.05. 
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Table 4 
Results for Question 4. One-way ANOVA and Scheffe Post Hoc Results for Outcome Rating 
Variables in Country of Origin Groups 
Variable F (df) p Post Hoc Differences 
Most Recent ORS Total F (10, 4924) = 16.363  p < 0.001 AU < NL, UK, US 
UK > AU, CA, DK, NZ, SE, US 
Average ORS Total F (10, 5030) = 31.363 p < 0.001 NL  > AU, CA, NZ, UK 
UK > AU, CA, DK, NL, NZ,  
          NO, RO, SE, US 
US > AU, CA, NZ, UK 
Average ORS in first 8 
Sessions 
F (10, 5030) = 29.379 p < 0.001 AU < NL, UK, US 
NL > AU, CA, NZ 
NZ < NL, UK, US 
UK > AU, CA, DK, NL, NZ,  
          NO, RO, SE, US 
Average ORS Change  F (10, 3462) = 7.142  p < 0.001 AU > US 
NZ > NL, UK, US 
Average ORS Slope F (10, 3412) = 6.191  p < 0.001 NZ > NL, US, 
US < AU, NZ 
Treatment Duration F (10, 5187) = 24.863 p < 0.001 PH > AU, CA, DK, NZ,  
RO > AU, CA, NZ 
UK > AU, CA, DK, NL, NZ,       
          SE, US 
US > AU, CA, NZ, UK 
Note. Results include comparing outcome and treatment duration variables between eleven 
country groups: Australia (AU), Canada (CA), Denmark (DK), Netherlands (NL), New Zealand 
(NZ), Norway (NO), Philippines (PH), Romania (RO), Sweden (SE), United Kingdom (UK), and 
United States (US). 
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Table 5  
Results for Question 5. One-way ANOVA and Scheffe Post Hoc Results for Outcome and Session 
Ratings Between Diagnostic Groups 
Variable F (df) p Post Hoc Differences 
Most Recent ORS Total F (7, 541) = 2.103  p = .042 No post hoc differences < .05 
Average ORS Total F (7, 565) = 2.535  p = .014 No post hoc differences < .05 
Average ORS in first 8 
Sessions 
F (7, 565) = 2.546 p = .014 MD < CD 
Average ORS Change  F (7, 385) = .982  p = .444 No statistical differences 
Average ORS Slope F (7, 372) = .209  p = .983 No statistical differences 
Most Recent SRS Total F (7, 425) = 2.087  p = .044 No post hoc differences < .05 
Average SRS Total F (7, 515) = 3.118 p = .003 SA < AD, AX, CD 
Average SRS in first 8 
Sessions 
F (7, 515) = 3.175 p = .003 SA < AD, AX,CD 
Average SRS Change  F (7, 327) = .949 p = .469 No statistical differences 
Average SRS Slope F (7, 319) = .856 p = .542 No statistical differences 
Note. Results include comparing outcome and session ratings between eight diagnostic criteria 
groups: Adjustment Disorder (AD), Substance Abuse (SA), Anxiety disorder (AX), Eating 
disorder (ED), Personality disorder (PD), Mood disorder (MD), Child/adolescent disorder (CD) 
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Chapter 4 
Discussion 
 
 This study explored the use of the Therapeutic Outcome Management System (TOMS) 
mobile app to gather psychotherapy research data.  Five research questions were used to explore 
the potential of using the TOMS and also the limitations of using such technology.  The five 
questions explored differences in (a) therapeutic alliance when compared to treatment durations, 
(b) therapeutic alliance and treatment duration when comparing gender between client and 
therapist, (c) treatment duration and outcome ratings between various theoretical 
orientations/modalities, (d) outcome ratings and treatment duration between country of origin, 
and (e) therapeutic alliance and outcome ratings across diagnostic criteria.   
Summary of Findings 
 In response to the first research question, it appears that shorter-term therapy is associated 
with lower therapeutic alliance.  This was evident in the first session ratings, most recent session 
ratings, and average session rating scores.  Though significant differences were found, effect 
sizes are quite small.  It is also important to consider that within shorter-term psychotherapy 
group there might have been a significant number of drop outs that occurred for various reasons.  
A meta-analysis by Sharf et al. (2010) indicates that there are higher levels of drop-outs when 
therapeutic alliance is lower—a finding which is consistent with the results reported here.  The 
present findings also suggest that when treatment reaches eight sessions there were no significant 
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differences observed in therapeutic alliance between the shorter-term and longer-term 
psychotherapy groups. 
 The second research question suggested no significant differences between gender-
matched and mixed-gender client-therapist dyads in the current study.  Add The most recent SRS 
total, average SRS total, average SRS in first 8 sessions, and average SRS change variables did 
not provide significant differences between the two groups.  Likewise, the analysis on the 
treatment duration between the two groups suggested no significant differences.  This was 
contrary to the results reported by Wintersteen et al. (2005) which suggested that gender-
matched dyads have higher therapeutic alliance and that their clients are more likely to complete 
treatment.   
 The third research question considered the association between psychotherapist 
theoretical orientation/modality, outcome rating, and treatment duration.  The “other” theoretical 
orientation/modality was statistically greater in the average ORS total and average ORS in first 8 
sessions when compared to cognitive-behavioral, integrative, eclectic, family systems, and 
interpersonal approaches.  Apart from the “other” theoretical orientation/modality option, few 
differences were observed in the outcome rating variables across the various theoretical 
orientation/modalities.  The cognitive-behavioral group was found to have lower most recent 
ORS total scores than integrative, eclectic, and those with “other” as a theoretical 
orientation/modality.  Statistical significant differences were also observed among treatment 
duration and theoretical orientations/modalities.  Integrative and Family Systems groups were 
found to have the statistically higher number of sessions.  Cognitive-Behavioral and Emotion-
Focused groups were found to have the least number of sessions. 
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 The fourth research question considered therapy outcome and treatment duration in 
various countries where psychotherapy is being conducted.  Many differences were observed 
between outcome ratings and selected country.  Individuals in the United Kingdom tended to rate 
their outcome more favorably when compared to most of the other countries.  This was evident 
across three different variables for outcome ratings scores.  Interestingly, the results also 
indicated that clients in the UK also stayed in treatment statistically longer than clients in most 
other countries.  Individuals in Australia tended to have statistically significantly lower outcome 
ratings on their most recent rating when compared to the United States, United Kingdom, and 
Netherlands.  
 The last research question considered outcome and therapeutic alliance between various 
diagnostic groups.  These results revealed few statistical differences among groups.  However, 
individuals with a child/adolescent disorder had statistically higher average outcome ratings in 
the first eight sessions when compared to mood disorders.  The substance abuse disorder group 
was also found to have statistically lower therapeutic alliance scores when compared to 
adjustment disorder, anxiety disorder, and child/adolescent disorder.   
Implications 
 The use of the Therapy Outcome Management System (TOMS) iOS app has many 
implications for researchers of psychotherapist data.  One of the most important implications is 
that the app allows for collection of big data due to its ease of access and public availability.  The 
app is available to anyone that has a device that allows iOS applications, thereby allowing for a 
very large sample size and providing the researcher with enough power to identify small 
statistical differences.   
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Detecting small differences has both advantages and disadvantages.  One advantage is 
that the power of the large samples may help detect subtle nuances that would otherwise not be 
observed in traditional efficacy studies.  Conversely, it is likely that these small differences – 
some of which have tiny effect sizes – might be exaggerated when considering clinical 
implications.    
The data collection reported here happens in real-time and continues to change with 
added Norm Development Associates and new clients.  This has at least two implications for the 
researcher.  First, the data and thus the results are continuously changing.  Second, the research 
can access a worldwide sample of therapists and their patients.  As is true of science in general, 
this calls for holding conclusions with some tentativeness and replicating studies often to see 
which conclusions stand the test of time. 
While traditional efficacy studies attempt to control for many variables and use 
manualized treatment when possible, using a mobile app to enables the researcher to sample 
therapeutic alliance and outcome directly in “real-life” clinical settings.  This means that the app 
collects information from clinics, clinicians, and patients from all over the world where this iOS 
app is available.  Global access to participate in psychotherapy research such as this app is due to 
the technological advances in smartphone technology.  With more countries and people around 
the world obtaining access to such technology, these types of apps that have the potential to 
gather psychotherapy data could be significant contributors to developments in clinical 
psychology literature.    
This type of data gathering is currently being utilized on a somewhat smaller scale in 
many large medical organizations in the collection of screeners such as the Patient Health 
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Questionnaire (PHQ-9) and SBIRT (Screening, Brief Intervention, Referral to Treatment).   
Although screeners and other measures are often used within both primary care and outpatient 
mental health clinics, the data are usually self-contained within that specific organization.  Many 
times they are being stored but not analyzed.  Moreover, paper and pencil are still being used in 
some primary care offices with patients, but with developments in technology these medical 
organizations might start using tablets and other forms of mobile technology for convenience, 
ease of service, and data analysis purposes.  If organizations start utilizing tablets and other 
mobile device the development of application such as the TOMS creates more opportunities for 
data collection across many organizations and the ability to reach those in smaller practices.  The 
benefit of this technology is that it does not only benefit individual organizations and researcher, 
but its individual benefit for clinicians.   
The TOMS app specifically provides good incentives for clinicians by its use of 
statistically valid and reliable measures.  The app is fairly easy to use, quick to administer, and 
shown to have no difference from paper and pencil administration of the SRS/ORS (Wiarda, 
2012).  The app allows clinicians to measure and monitor their therapeutic alliance and outcome 
of their clients, while contributing to an ever-growing data pool.   
This study looked at only five research questions, but the growing database might allow 
for research into more nuanced relationships within the SRS (such as relationship, goals and 
topics, approach or method, and overall).  For example, might there be observable differences 
between how clients within certain diagnostic criteria rate these specific variables within the 
SRS?  The larger the database grows the more opportunities there will be for finding statistical 
differences between individual variables.   
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Growing this type of research database can happen in at least two ways.  First, the 
application itself must be beneficial enough for clinicians to purchase and use regularly to 
continue growing the data.  Second, the app could be adopted by mental health or primary care 
organizations that have psychotherapy treatment.  Both of these routes pose some interesting 
ethical considerations.  
 Security and de-identification of client information is a crucial practice of mental health 
clinicians that must be extended when using technology such as the TOMS.  The TOMS app de-
identifies information through security algorithms and the data is uploaded for analysis.  
However, if and when using technology such as the TOMS app becomes more prevalent 
throughout private practice and medical organizations, extensive efforts will need to be taken to 
ensure the de-identification and security of the data, especially if the data will be used for 
research analysis.  Access to this data is another thing that should be considered.  Nunan and 
Domenico (2013) point out how currently in our society big data is gathered through a number of 
high-technological firms such Facebook, Google, and other companies that obtain a vast amount 
of market research.  The collection of big data raises the question of data ownership and how this 
data is potentially used.  It is important that respondents, both the clinician and client understand 
how this data will be used.  Some organizations might use outcome data to demonstrate whether 
a certain clinician is effective as therapist, which could have implications for compensation and 
employability.  Another ethical concern is misinterpreting statistical significance from big data.  
As noticed in the results, although there were statistical significance found in the data, the effect 
sizes were quite small.  Competent and careful interpretation of this data is very important, and 
similarly the limitations of this research technique must be understood.   
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Limitations 
 Many of the limitations of using an app such as the TOMS for data gathering are identical 
to the traditional limitations of effectiveness studies.  There are no stringent controls like in 
traditional efficacy studies.  This leads to a high likelihood of confounding variables.  Although 
it might be interesting to study differences between geographic differences and ratings scores, 
the researcher cannot assess for cultural, social, economic, and clinical factors that are present in 
each therapy room where the app is being used.  Lack of stringent controls and framework of the 
app allows for certain data not to be entered.  This makes it difficult to obtain complete results in 
each therapy session input.  For example, most patients did not have an entered ethnic group 
which makes it difficult to observe cultural and ethnic sensitivities.   
Another limitation is the need for large sample sizes.  Depending on the research question 
in mind, certain observations and comparisons might not have enough sample to make the 
appropriate analysis.  One challenge in the current study was the vast discrepancy in sample sizes 
of different groups when trying to compare country of origin or diagnostic criteria differences.  
There were certain countries and diagnostic criteria that were more prevalent and had a 
significantly larger sample sizes.  This type of data gathering tool is largely dependent on the 
sample size and more importantly on the diversity of data that is obtained.  In efficacy studies, 
the researcher has the privilege to find the population or sample they want to study.  In 
effectiveness studies, particularly Seligman’s (1995) Consumer Reports study, the data gathering 
was open ended and voluntary.  This is similar in the case of the TOMS app, in which the 
researcher is extremely dependent the app is utilized in its entirety by mental health clinicians.   
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Another limiting factor of this type of psychotherapy research gathering method is that 
the mobile application in question must provide strong benefits and incentives to the user.  
Clinicians must benefit from the purchase and use of this technology.  This technology must be 
easy to use, regularly maintained, updated for new devices and software, and stay relevant to 
clinician’s needs.  If independent clinicians find little incentives to use this app, or encounter 
issues with the software, the sample sizes and data gathering will slow.  If organizations decide 
to adopt this type of outcome and therapeutic alliance measurement tool, there might be 
challenges around security and successful integration of the app into the electronic 
health/medical record.  Smaller samples sizes will significantly hinder the potential study of this 
data set.  Regularly updating this type of software also becomes paramount as clinical 
psychology research is developing.  For example, this application was developed using DSM-IV-
TR diagnostic criteria domains and currently the profession of clinical psychology has adopted 
the Diagnostic and Statistical Manual of Mental Disorders, 5
th
 Edition (DSM-5, 2013).   
Future Directions 
 As technology has developed, so have the implications for researcher and clinicians in the 
field of clinical psychology.  The TOMS has obvious implications for research and clinical use.  
This technology has much potential, which can be explored by continuous developments and 
data gathering by the TOMS and similar applications.  Larger samples and diverse distribution of 
the app will offer more usable data and will allow better analysis. 
New developments including mobile applications that utilize other screeners or 
measurement tools for clinical use could serve a similar purpose as the TOMS.  Currently, many 
clinicians and organizations benefit from using the Patient Health Questionnaire (PHQ-9), 
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Patient Activation Measure (PAM), SBIRT, and other measures that health track patient data.  
Mobile applications, especially if adopted for use by large medical organizations, will provide a 
way to gather research data easier and effectively. 
The TOMS app itself has strong potential and offers many other paths for data analysis 
that were not observed in this study.  One specific study that would help evaluate the 
effectiveness of using the TOMS for research data gathering is to observe how much of the data 
collected is complete and “usable” for research.  Consistency of clinician use of the TOMS app 
after purchase is another question that might warrant research.  This will also provide important 
feedback to the developer of the app regarding how regularly and consistently clinicians use their 
application.  Further in-depth research can also be conducted into looking at the whether there 
are observed differences between the four individual variables in each of the SRS and ORS 
measures.  This particular study looked primarily at overall SRS and ORS scores.  However, if 
the database grows to a substantial size, individual differences and correlations might be 
observed between the various variables of the SRS and ORS.   
Conclusion 
The future of technology advancement is unforeseen, but likely monumental.  The 
application of apps such as the TOMS provides a new method of gathering psychotherapy 
research that was previously unobtainable on such a large scale.   
In 2005, the American Psychological Association Presidential Task Force on Evidence-
Based Practice wrote a report discussing the rationale and importance of Evidence-Based 
Practice in Psychology (EBPP).  The APA defined EBPP as “the integration of the best available 
research with clinical expertise in the context of patient characteristics, culture, and preferences” 
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(APA, 2006, p. 273).  At first, clinical research primarily focused on efficacy studies with 
stringent controls to demonstrate strong relationships between treatment and outcomes.  With the 
Consumer Reports study, Seligman (1995) was able to demonstrate how effectiveness studies 
provide an important role in the clinical research field.  Effectiveness studies provide research 
with potential for diverse sampling, non-manualized treatment, and high external validity.  With 
developments in mobile technology, using apps such as the TOMS provide a new opportunity 
and larger expansion to the original format of effectiveness research.  Mobile technology 
promotes even larger sample sizes on a global level, data gathering directly in clinical settings, 
and active participation from clinicians within private practice or larger organizations.  There are 
still much to learn and discuss regarding the use of mobile applications for gathering of 
psychotherapy research data.  There are many important benefits and limitations for both the 
clinician and researcher using these types of apps.  However, with developments in technology 
and shifts towards big data gathering, the TOMS app demonstrates how mobile applications can 
be used to gather this type of psychotherapy data.  More importantly, this new method of 
gathering data provides more research that promotes psychologists’ efforts to integrate research 
with clinical expertise in the field of clinical psychology. 
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Appendix A 
 
Session Rating Scale (SRS V.3.0) 
 
 
Name ________________________Age (Yrs):____ 
ID# _________________________ Gender:_______ 
Session # ____  Date: ________________________ 
 
Please rate today’s session by placing a mark on the line nearest to the description that best 
fits your experience.   
 
Relationship 
 
 
I-------------------------------------------------------------------------I 
 
 
Goals and Topics  
 
I------------------------------------------------------------------------I 
 
 
Approach or Method 
 
I-------------------------------------------------------------------------I 
 
 
Overall 
 
 
I------------------------------------------------------------------------I 
 
 
International Center for Clinical Excellence 
_______________________________________ 
www.scottdmiller.com  
 
 
© 2002, Scott D. Miller, Barry L. Duncan, & Lynn Johnson 
I felt heard, 
understood, and 
respected. 
I did not feel heard, 
understood, and 
respected. 
We worked on and 
talked about what I 
wanted to work on and 
talk about. 
We did not work on or 
talk about what I 
wanted to work on and 
talk about. 
Overall, today’s 
session was right for 
me. 
There was something 
missing in the session 
today. 
The therapist’s 
approach is a good fit 
for me. 
The therapist’s 
approach is not a 
good fit for me. 
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Appendix B 
Outcome Rating Scale (ORS) 
 
 
Name ________________________Age (Yrs):____ Gender_____________ 
Session # ____  Date: ________________________ 
Who is filling out this form? Please check one: Self_______ Other_______    
If other, what is your relationship to this person? ____________________________ 
 
Looking back over the last week, including today, help us understand how you have been 
feeling by rating how well you have been doing in the following areas of your life, where 
marks to the left represent low levels and marks to the right indicate high levels. If you are 
filling out this form for another person, please fill out according to how you think he or she 
is doing. 
 
Individually 
(Personal well-being) 
 
I----------------------------------------------------------------------I 
 
Interpersonally 
(Family, close relationships) 
 
I----------------------------------------------------------------------I 
 
Socially        
(Work, school, friendships) 
 
I----------------------------------------------------------------------I 
 
Overall 
(General sense of well-being) 
 
I----------------------------------------------------------------------I 
 
International Center for Clinical Excellence 
_______________________________________ 
www.scottdmiller.com  
 
© 2000, Scott D. Miller and Barry L. Duncan 
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Appendix C 
Curriculum Vitae 
Timofey S. Galuza 
 
8240 SE Buford Ln. 
Portland, OR 97236 
503-841-8959 
tgaluza11@georgefox.edu 
 
 
EDUCATION 
 
Doctor of Psychology, Clinical Psychology     Expected May 2016  
George Fox University, Newberg, OR 
Doctoral Dissertation: Prelim completed Sept. 2014 
Graduate Department of Psychology: APA Accredited 
 
Pre-doctoral Internship      Aug. 2015-Aug. 2016 
  George Fox Integrated Care Internship 
  Newberg, OR 
  APA Accredited Internship  
 
Master of Arts, Clinical Psychology           Dec. 2013
 George Fox University, Newberg, OR 
Graduate Department of Psychology: APA Accredited 
 
Bachelor of Arts, Psychology             May 2011  
University of Portland, Portland, OR 
 
 
DOCTORAL INTERNSHIP  
 
Aug. 2015 – Present  George Fox Integrated Care Internship Newberg, OR 
Behavioral Health Intern – PMG Happy Valley      
 Provide short-term, solution focused behavioral health services within an 
integrated primary care and behavioral health model for patients of varying age, 
gender, sexual orientation, ethnicity, and socioeconomic status, including 
underserved populations.   
 Services provided include brief solution focused psychotherapy, behavioral health 
consultations, treatment planning, crisis management, participation in warm 
handoffs,  
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 Engaged in coordination of care as part of multidisciplinary team of physicians, 
nurses, physician assistants, licensed clinical social workers, and pharmacists. 
 Other responsibilities include medical chart notes, chart review, consultation with 
supervisors, participation in interdisciplinary meetings, and participation in 
weekly supervision and didactic meetings. 
 Provide weekly supervision for clinical psychology doctoral candidates in 
community mental health clinic practicum site which includes face to face 
supervision, therapy video review, clinical notes review, and clinical training 
support.   
 Conducting an evaluation on patient satisfaction and staff ability in regards to 
behavioral health integration across Providence Medical Group clinics with a 
behavioral health provider. 
 Supervisors: Dr. Vanessa Casillas, Psy.D and Dr. Joel Gregor, Psy.D.  
 
 
SUPERVISED CLINICAL EXPERIENCE  
 
Aug. 2014 – July 2015 Willamette Family Medical Center  Salem, OR 
Behavioral Health Intern  
 Provide short-term behavioral health services within a co-located primary care 
and mental health model for patients for predominately underserved populations.  
 Services provided include psychotherapy, psychodiagnostic assessment, treatment 
planning, crisis management, behavioral consultations, and participation in warm 
handoffs. 
 Engaged in coordination of care as part of multidisciplinary team of physicians, 
nurse practitioners, physician assistants, and licensed clinical social workers. 
 Other responsibilities include medical chart notes, chart review, consultation with 
supervisors, assessment report writing, and participation in weekly supervision 
and didactic meetings. 
 Supervisors: Joel Gregor, Psy.D. and Joshua English, LCSW 
 
Aug. 2013 – Aug. 2014 GFU Behavioral Health Clinic  Newberg, OR 
Assessment Coordinator and psychotherapist 
 Provided comprehensive assessments for clients seeking psychological testing for 
learning disabilities, Attention Deficit/Hyperactivity Disorder, Autism, 
personality/behavior assessments, neurocognitive disorders, conduct disorders, 
and other reasons for assessment.  This includes conducting client interviews, test 
administration, scoring, report writing, diagnosis, and making post-assessment 
feedback and recommendations. 
 Conducted intake interviews, treatment planning, and administrative duties. 
 Provided psychotherapy to individuals in the community. 
 Provided group therapy for clients managing chronic pain. 
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 Engaged in weekly didactic training that focused on assessment training, case 
conceptualization, group therapy skills, teaching parenting skills, and diagnosis-
specific treatment. 
 Assessment scoring, interpretation, reports, therapy sessions, and therapy 
documents were reviewed during individual supervision. 
 Supervisor: Dr. Joel Gregor, Psy.D. 
 
Sept. 2012 – June 2013 Milwaukie High School   Milwaukie, OR 
School Counselor/Psychotherapist 
 Provided weekly individual therapy for high school students struggling with 
academic, emotional, or social issues. 
 Provided intake interviews, observations, consultation, treatment planning, and 
report writing. 
 Participated in multidisciplinary meetings to design Individualized Education 
Plans, Functional Behavioral Assessments, and Behavioral Support Plans. 
 Provide psychological assessments to determine students’ levels of functioning 
and their eligibility for special education services. 
 Therapy interventions, documents, and assessment reports were reviewed in 
individual and group supervision. 
 Supervisors: Dr. Leslie Franklin, Psy.D. and Dr. Fiorella Kassab, Ph.D.  
 
Jan. 2012 – May 2012 George Fox University   Newberg, OR 
Pre-Practicum II 
 Provided individual psychotherapy services for volunteer undergraduate students. 
 Services included intake interviews, treatment planning, progress notes, and 
diagnosis. 
 Tasks included report writing, case presentations, consultation with supervisor 
and clinical team members. 
 Conducted personality assessments and wrote evaluations. 
 Supervisor: Mary Peterson, Ph.D., and Laura Heyne, M.A. 
 
Aug. 2011 – Dec. 2011 George Fox University    Newberg, OR 
Pre-Practicum I 
 Learned basic person-centered therapy skills with group members. 
 Tasks included: intake interviews and treatment planning. 
 All sessions were taped and reviewed during supervision. 
 Supervisors: Mary Peterson, Ph.D., and Laura Heyne, M.A. 
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RELEVENT EXPERIENCE & UNIVERSITY INVOLVEMENT  
  
Oct. 2013 – May 2015 Reflex Clinic  
Consultant       Tigard, OR 
 Provided industrial and organizational psychology consultation services to 
evaluate the workplace system and recommend changes to improve employee 
review and hiring processes. 
 Conducted research-based diagnostics of workplace and performance issues. 
 Continued monitoring of system improvements and processes. 
 Mapping workplace system, culture, and processes for future replication and 
business expansion. 
 
April – Aug. 2014 George Fox Graduate Department of Clinical Psychology 
Graduate Teacher Assistant for Social Psychology     Newberg, OR 
 Optimized visual presentation through review and modification of PowerPoint 
slides, inclusion of relevant videos, and other methods to improve visual 
presentations. 
 Graded writing assignments and input grades. 
 Provided assistance and guidance to students.  
 Supervisor: Joel Gregor, Psy.D. 
 
April 4-6, 2013      Christian Association for Psychological Studies International Conference  
Presenter, Volunteer, and CE Monitor      Portland, OR 
 Conducted research presentation 
 Monitored attendance and CE sign in/sign out. 
 Helped set up the seating and introduced presenters.  
 Provide assistance and information to presenters and attendees. 
 
May 2010 – June 2010 Autism Intervention Internship   Portland, OR 
Intern 
 Partook in a play-based treatment program with an autistic boy, followed specific 
guidelines and goals set by the Son-Rise program to help him develop language 
and social skills in a positive and supportive environment. 
 Built a genuine and fun relationship with the child, while striving to increase 
communication, interactive attention span, flexibility, and eye contact.   
 Focused on using the child’s motivations and interests, and building upon them to 
improve social skills and communication.  
 
PROFESSIONAL AFFILIATIONS 
 
2012 – Present  Oregon Psychological Association (Student Affiliate) 
2011 – Present  American Psychological Association (Student Affiliate) 
2010 – Present  Psi Chi National Honor Society 
BIG DATA FOR RESEARCH 51 
 
RESEARCH EXPERIENCE & PRESENTATIONS 
 
Feb. 2011 – May 2015 Graduate Department of Clinical Psychology 
Research Vertical Team Member      Newberg, OR 
 Participate in bi-weekly meetings to discuss research projects, including 
dissertations, supplemental research, research conferences, and other topics 
relating to research. 
 Presented personal dissertation research and progress.   Collaborated on group 
research projects, and discussed research ideas for future projects 
 Faculty Advisor: Mark McMinn, Ph.D. 
 
Doctoral Dissertation: Using Big Data in Psychotherapy Research: Possibilities and Perils 
 Dissertation Chair: Mark McMinn, Ph.D., ABPP/CL 
 Committee Members: Mary Peterson, PhD, ABPP; Joel Gregor, Psy.D. 
 Preliminary defense completed: Sept. 24, 2014 
 
Presentations: 
Engle, N. W., Barr, B., Galuza, T. (2014, May). Organizational psychology for medical  
clinic culture. Poster presented at annual meeting of the Oregon Psychological 
Association, Portland, OR 
 
McMinn, M. R., Birch, R., Galuza, T., & Rodriguez, J. M., (2013, April). A Comparison  
of Religious and Spiritual Diversity Training at Religious and other 
Institutions.  Presentation at the annual meeting of the Christian Association of 
Psychological Studies, Portland, OR. 
 
Rodriguez, J. R., Birch, R., Galuza, T., & McMinn, M. R. (2013, August). Religious and  
Spiritual Diversity Training at Explicitly Religious Doctoral Programs. Poster 
was presented at the annual meeting of the American Psychological Association, 
Honolulu, HI 
 
 
PROFESSIONAL TRAINING AND WORKSHOPS 
 
Nov. 7-8, 2015 Acceptance & Commitment Therapy - An Experiential and Practical 
Introduction 
 Dr. Jason Luoma, Ph.D. and Dr. Jenna LeJeune, Ph.D. 
 Site: LifeQual Center 
 
Oct. 21, 2015  Let’s talk about Sex: Managing Emerging Sexuality in Therapy 
   Dr. Joy Mauldin, Psy.D. 
   Site: George Fox University 
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Aug. 10-14, 2015 Integrated Care Bootcamp 
Dr. Joel Gregor, Psy.D., Dr. Mary Peterson, Ph.D., Jeri Turgesen, Psy.D., 
Vanessa Casillas, Psy.D., Juliette Cutts, Psy.D., Kristin Garcia, Psy.D., 
Julie Oyemaja, Psy.D., and Joy Mauldin, Psy.D. 
   Site: George Fox University 
 
March 18, 2015 Spiritual Formation & Psychology 
   Dr. Barrett McRay, Psy.D. 
   Site: George Fox University 
 
Feb. 26, 2015  Workshop on Criminal Justice-Behavioral Health Issues 
Dr. Annette Matthews, MD, Dr. Jonathan Barker, MD, Jason Myers, Dr. 
Stephanie Maya Lopez, MD, and Dr. Karl Mobbs, MD. 
Oregon Psychiatric Physician’s Association in partnership with the 
American Psychiatric Association 
   Site: DoubleTree by Hilton Portland 
 
Nov. 19, 2014  Face Time in an Age of Technological Attachment 
   Dr. Doreen Dodgen-Magee, Psy.D. 
   Site: George Fox University 
 
Oct. 15, 2014  Understanding and Treating ADHD in Children 
   Dr. Erika Doty, Psy.D. 
   Learning Disabilities: A Neuropsychological Perspective 
   Dr. Tabitha Becker, Psy.D 
Site: George Fox University 
 
Aug. 18-22, 2014 Workplace Development for Integrated Behavioral Healthcare 
Dr. Joel Gregor, Psy.D., Dr. Julie Oyemaja, Psy.D., Dr. Mary Peterson, 
Ph.D., Dr. Jeri Turgesen, Psy.D. 
Site: George Fox University 
 
March 12, 2014 Evidenced Based Treatment for PTSD in Veteran Populations: 
Clinical and Integrative Perspectives 
 Dr. David Beil-Adaskin, Psy.D. 
 Site: George Fox University 
 
Jan. 15, 2014  DSM V, Essential Changes in Form and Function 
   Dr. Jeri Turgesen, Psy.D. and Dr. Mary Peterson, Ph.D., ABPP 
   Site: George Fox University 
 
Sept. 25, 2013  Integrated Primary Care 
   Dr. Brian Sandoval, Psy.D. and Dr. Juliette Cutts, Psy.D. 
   Site: George Fox University 
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May 31, 2013 Psychological Assessment Conference: Using Tests of Effort in 
Psychological Assessment  
Dr. Paul Green, Ph.D.  
Site: George Fox University 
 
May 31, 2013  Assessing Mild Cognitive Impairment and Dementia  
Dr. Mark Bondi, Ph.D., ABPP   
   Site: George Fox University 
 
March 6, 2013  The Person of the Therapist 
   Dr. Brooke Kuhnhausen, Ph.D. 
   Site: George Fox University 
 
Jan. 30, 2013 African American History, Culture and Addictions and Mental 
Health Treatment 
   Danette C. Haynes, LCSW, and Dr. Marcus Sharpe, Psy.D. 
   Site: George Fox University 
 
Nov. 14, 2012  Sexual Identity 
Dr. Erica Tan, Psy.D. 
Site: George Fox University 
 
Oct. 10, 2012  Treating Gender Variant Clients: Christian Integration 
Dr. Erica Tan, Psy.D. 
Site: George Fox University  
 
June 8, 2012 Psychological Assessment Conference: Assessment and Treatment of 
Anger, Aggression, & Bullying in Children and Adults; and The Mini-
Mental State Examination – 2nd Edition  
 Dr. Ray DiGiuseppe, Ph.D., and Dr. Joel Gregor, Psy.D. 
   Site: George Fox University 
 
March 7, 2012  Mindfulness and Christian Integration 
  Dr. Erica Tan, Psy.D 
  Site: George Fox University 
 
 
LANGUAGES SPOKEN 
 
English, Russian 
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TEST ADMINISTRATION, SCORING, AND REPORT WRITING EXPERIENCE 
 
Adult Measures (and wide age-range measures) 
 16PF – Fifth Edition  
 Adaptive Behavior Assessment System – Second Edition (ABAS-II) 
 Adult Asperger Assessment (AAA) 
 Becks Depression Inventory-II (BDI-II) 
 Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A) 
 California Verbal Learning Test – 2nd Edition (CVLT-II) 
 Conners’ Adult ADHD Rating Scales (CAARS) 
 Conners’ Continuous Performance Test II (CPT II V.5) 
 Controlled Oral Word Association (COWA) 
 Delis-Kaplan Executive Function System (D-KEFS) 
 Halstead-Reitan Neuropsychological Battery 
 Millon Clinical Multiaxial Inventory – III (MCMI-III)  
 Minnesota Multiphasic Personality Inventory – II (MMPI-II)  
 Minnesota Multiphasic Personality Inventory – II – RF (MMPI-II-RF) 
 Minnesota Multiphasic Personality Inventory – Adolescent (MMPI-A) 
 Peabody Picture Vocabulary Test -  Fourth Edition (PPVT-4) 
 Personality Assessment Inventory (PAI)  
 Rey Complex Figure Test and Recognition Trial (RCFT) 
 Ritvo Autism-Asperger’s Diagnostic Scale – Revised (RAADS-R) 
 Test of Memory Malingering (TOMM) 
 Vineland Adaptive Behavior Scales, 2nd Edition 
 Wechsler’s Adult Intelligence Scale – Fourth Edition (WAIS-IV) 
 Wechsler’s Individual Achievement Test- Third Edition (WIAT-III)  
 Wide Range Intelligence Test (WRIT) 
 Wide Range Achievement Test – Fourth Edition (WRAT4) 
 Wide Range Assessment of Memory and Learning – Second Edition (WRAML-2) 
 Wisconsin Card Sorting Test (WCST) 
 Woodcock-Johnson Tests of Achievement – Third Edition (WJ-III) 
 
Child and Adolescent Measures  
 Achenbach Child Behavior Checklist (CBCL) 
 Behavioral Assessment System for Children, Second Edition (BASC-II) 
 Behavior Rating Inventory of Executive Function (BRIEF) 
 Child Bipolar Questionnaire (CBQ) – Version 2.0 
 Childhood Autism Rating Scale, 2nd Ed. (CARS2) 
 Conners 3rd Edition (Conners 3) 
 Gilliam Asperger’s Disorder Scale (GADS) 
 Millon Pre-Adolescent Clinical Inventory (M-PACI) 
 Personality Assessment Inventory – Adolescent (PAI-A) 
 Personality Inventory for Youth (PIY) 
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 Roberts Apperception Test for Children 2 (Roberts-2) 
 Wechsler’s Intelligence Scale for Children – Fourth Edition (WISC-IV) 
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